Literature DB >> 14644217

Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Gildo Y Fujii1, Eugene De Juan, Mark S Humayun, Janet S Sunness, Tom S Chang, Juliana V Rossi.   

Abstract

PURPOSE: To evaluate the effects of subfoveal choroidal neovascularization secondary to age-related macular degeneration on functional parameters obtained by scanning laser ophthalmoscope microperimetry.
DESIGN: Retrospective observational case series and cross-sectional study.
METHODS: At the Doheny Retina Institute and Wilmer Eye Institute a consecutive series of 179 eyes of 175 patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration was studied. The onset of visual symptoms, best-corrected visual acuity, fluorescein angiography, evaluation of fundus microperimetry and fixation pattern using the Rodenstock scanning laser ophthalmoscope were obtained for each patient. The main outcome measures were central retinal sensitivity and fixation pattern (fixation location and fixation stability) in eyes with subfoveal choroidal neovascularization and their relationship to the length of disease, type and characteristics of choroidal neovascularization, and visual acuity.
RESULTS: Of 179 eyes, 135 (75%) had central fixation, 27 (15%) had poor central fixation, and 17 (9%) had predominantly eccentric fixation. Seventy-six eyes (42%) had stable fixation, 70 eyes (39%) had relatively unstable fixation, and 33 eyes (18%) had unstable fixation. In 50 eyes (28%) a dense central scotoma was noted. Eighty-nine of 100 eyes (89%) with length of symptoms of less than 3 months had predominantly central fixation and 58 (58%) had stable fixation; 14 of 34 eyes (41%) with length of symptoms of more than 6 months had predominantly central fixation, and 5 eyes (15%) had stable fixation. In 15 eyes of patients who elected not to receive treatment, successive scanning laser ophthalmoscope microperimetry were obtained over time (follow-up of 18 months after onset of symptoms). Three months or less after the onset of symptoms, 13 eyes (87.7%) had predominantly central fixation and 9 eyes (60%) had stable fixation. More than 3 months and 6 months or less after the onset of symptoms, 10 eyes (66.7%) had predominantly central fixation and 7 eyes (46.7%) had stable fixation. This trend was further demonstrated in eyes more than 6 months after the onset of symptoms.
CONCLUSIONS: We conclude that the sequence of events leading to visual function deterioration appears to involve an initial mild decrease in central retinal sensitivity and visual acuity followed by progressive fixation instability and, ultimately, development of an absolute central scotoma with totally eccentric fixation. Increased length of disease is associated with worse fixation pattern and retinal sensitivity deterioration as assessed by scanning laser ophthalmoscope microperimetry. A better understanding of the characteristics of visual loss assessed by fixation pattern evaluation and microperimetry in age-related macular degeneration may help optimize timing, patient selection, and treatment options in eyes with this condition.

Entities:  

Mesh:

Year:  2003        PMID: 14644217     DOI: 10.1016/s0002-9394(03)00663-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  28 in total

1.  Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.

Authors:  S Sivaprasad; E Pearce; V Chong
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

2.  Fixation behavior in advanced stage glaucoma assessed by the MicroPerimeter MP-1.

Authors:  Takanori Kameda; Teruyo Tanabe; Masanori Hangai; Tomonari Ojima; Hiroko Aikawa; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2009-12-18       Impact factor: 2.447

3.  Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivity.

Authors:  E Hatef; M Hanout; A Moradi; E Colantuoni; M Bittencourt; H Liu; Y J Sepah; M Ibrahim; D V Do; D L Guyton; Q D Nguyen
Journal:  Eye (Lond)       Date:  2014-08-08       Impact factor: 3.775

4.  Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1).

Authors:  R Mathew; E Pearce; R Muniraju; A Abdel-Hay; A Abdul-Hey; S Sivaprasad
Journal:  Eye (Lond)       Date:  2014-01-03       Impact factor: 3.775

Review 5.  Functional and cortical adaptations to central vision loss.

Authors:  Sing-Hang Cheung; Gordon E Legge
Journal:  Vis Neurosci       Date:  2005 Mar-Apr       Impact factor: 3.241

6.  The use of the scanning laser ophthalmoscope in the evaluation of amblyopia (an American Ophthalmological Society thesis).

Authors:  David A Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema.

Authors:  Romualdo Malagola; Giovanni Spinucci; Carmela Cofone; Luigi Pattavina
Journal:  Int Ophthalmol       Date:  2012-12-14       Impact factor: 2.031

8.  Fixation stability and scotoma mapping for patients with low vision.

Authors:  Ann E Elsner; Benno L Petrig; Joel A Papay; Elli J Kollbaum; Christopher A Clark; Matthew S Muller
Journal:  Optom Vis Sci       Date:  2013-02       Impact factor: 1.973

9.  Atypical retinotopic organization of visual cortex in patients with central brain damage: congenital and adult onset.

Authors:  Danielle C Reitsma; Jedidiah Mathis; John L Ulmer; Wade Mueller; Mary J Maciejewski; Edgar A DeYoe
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

10.  Microperimetry - A New Tool for Assessing Retinal Sensitivity in Macular Diseases.

Authors:  Memota Laishram; Krishnagopal Srikanth; A R Rajalakshmi; Swathi Nagarajan; G Ezhumalai
Journal:  J Clin Diagn Res       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.